1263213

Medpace, Inc. — FEI 3009316555

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 13, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)